Stay updated on Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual content and leaving a simple Home link. This means the record is temporarily inaccessible and trial details are not viewable on this page.
    Difference
    19%
    Check dated 2026-09-19T18:36:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    NIH funding entries for 2017 and 2023 were added to the page. The revision history now shows v3.6.6, and the previous v3.6.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-08-29T19:39:58.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The Plain Language Summary section was removed from the study record page, eliminating the patient-friendly overview of the trial and its purpose.
    Difference
    0.0%
    Check dated 2026-08-15T20:08:19.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    - The page revision has been updated to v3.6.5. The previous revision indicator v3.6.4 has been replaced.
    Difference
    0.0%
    Check dated 2026-08-08T18:29:51.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The study record now includes new registry identifiers (UTN and EU CT) and adds data-sharing resources: a PDF with data-access procedures and an external data-sharing site, while older EngageZone links were removed. These changes place the trial's data-sharing framework and identifiers into current reference points for researchers and stakeholders.
    Difference
    0.1%
    Check dated 2026-08-01T15:24:50.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the underlying documentation/system. This change is an internal version update rather than a visible content update.
    Difference
    0.0%
    Check dated 2026-07-25T11:42:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.